Efficacy and safety of chaperonin 10 in patients with moderate to severe plaque psoriasis: evidence of utility beyond a single indication.
Williams
Bronwyn
B
Vanags
Daina
D
Hall
Stephen
S
McCormack
Chris
C
Foley
Peter
P
Weiss
Julissa
J
Johnson
Barbara
B
Latz
Eicke
E
Feeney
Dennis
D
D000328:Adult; D000368:Aged; D018835:Chaperonin 10 / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology*; D012720:Severity of Illness Index; D016896:Treatment Outcome
D018835:Chaperonin 10